Projects per year
Search results
-
Active
Nuclear forms of AXL and TYRO3 receptors in bladder cancer
Tulchinsky, E. (PI), Kriajevskaia, M. (Other Faculty/Researcher) & Bryan, R. T. (Other Faculty/Researcher)
2/4/25 → 12/31/27
Project: FDCRGP
-
TAM receptors in bladder cancer: prospective targets and liquid biomarkers
Tulchinsky, E. (PI)
1/1/24 → 12/31/26
Project: Government
-
Periostin in bladder cancer: EMT, metastatic potential and potential crosstalk with the TAM receptor signaling.
Riethmacher, D. (PI), Riethmacher, E. (Co-PI), Tulchinsky, E. (Other Faculty/Researcher), Gushchin, D. (Other Faculty/Researcher), Bryan, R. T. (Other Faculty/Researcher) & Ward, D. (Other Faculty/Researcher)
1/1/24 → 12/31/26
Project: FDCRGP
-
Proteolytic processing of TAM receptors: implications for the biology of bladder cancer and use as urine biomarkers
Kriajevskaia, M. (PI), Tulchinsky, E. (Co-PI), Tanko, M. N. (Co-PI) & Shalekenov, S. B. (Co-PI)
1/1/23 → 12/31/25
Project: FDCRGP
-
Dissecting Zeb1-mediated regulation of p53 during epithelial-mesenchymal transition (EMT) in cancer
Barlev, N. (PI) & Tulchinsky, E. (Co-PI)
1/1/23 → 12/31/25
Project: FDCRGP
-
Finished
Epithelial mesenchymal transition mobilizes transposable genetic elements, drives genetic diversity and regulates expression of inflammatory genes in cancer cells
Tulchinsky, E. (PI), Singh, P. (Co-PI) & Schoenbach, C. (Co-PI)
1/2/20 → 12/31/22
Project: FDCRGP
-
AXL and TYRO3 signaling pathways as therapeutic targets in bladder cancer: preclinical study
Kriajevskaia, M. (PI), Tulchinsky, E. (Co-PI) & Ogay, V. (Co-PI)
1/1/20 → 7/4/23
Project: FDCRGP